The Remuneration Policy was adopted at the April 13, 2021 Annual General Meeting. Additionally, the Compensation Report is available and describes the details of the compensation of the Board of Directors of Genmab A/S and our Executive Management officers in respect of the financial year 2020. The decisions made by the Board of Directors were made in accordance with the then effective Remuneration Policy. The 2020 Compensation Report has been prepared in compliance with the Danish Corporate Governance Recommendations on remuneration reports. The Compensation Report also includes disclosures that are not required by law but that Genmab thinks are helpful for shareholders to understand Genmab A/S’ approach to executive compensation and Board of Directors’ compensation.